ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $71,000 | -22.0% | 11,718 | -53.7% | 0.01% | 0.0% |
| Q3 2019 | $91,000 | +133.3% | 25,291 | +72.1% | 0.01% | +250.0% |
| Q2 2019 | $39,000 | +18.2% | 14,699 | +32.0% | 0.00% | 0.0% |
| Q1 2019 | $33,000 | -42.1% | 11,136 | -28.3% | 0.00% | -33.3% |
| Q3 2018 | $57,000 | -58.4% | 15,535 | -67.3% | 0.00% | -57.1% |
| Q4 2017 | $137,000 | -58.1% | 47,499 | -34.8% | 0.01% | -56.2% |
| Q3 2017 | $327,000 | – | 72,803 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |